Coya Therapeutics has received 9 bullish analyst ratings in the last quarter, which indicates a positive outlook for the stock. The average price target of $18.33 is significantly higher than its current price of $4.715, suggesting a potential upside. The increase in the average price target by 103.67% over the past month further supports the bullish sentiment.